Intellectual Property

Vitadisc is a porcine origin biomatrix therapy that was originally developed at the Eindhoven University of Technology by Prof. Keita Ito’s team. This technology is patented for application in both the spine and synovial joint applications.

At NC Biomatrix, the technology has undergone multiple iterative rounds of formulation optimisation and in-vitro experimentation to select the right manufacturing steps that ensure that no animal cellular, bacterial or viral material is present in the final product, whilst retaining product potency.

Patents

Notochordal cell matrix as a stimulant for intervertebral disc regeneration

Number Region Granted
11607473B2 US 2022
EP3402542B1 EU 2022

Notochordal cell matrix as a bioactive lubricant for the osteoarthritic joint

Number Region Granted
7341504 JP 2023
11779609 US 2023
EP3746093 EU 2023